JPRN-UMIN000031241已完成未知
Clinical study of 5-ASA concentration in colonic mucosa for patients with ulcerative colitis - Clinical study of 5-ASA concentration in colonic mucosa for patients with ulcerative colitis
Keio University Division of Gastroenterology and Hepatology, Department of Internal Medicine0 个研究点目标入组 60 人开始时间: 2018年2月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have been 6 weeks or more past relapse diagnosis. Patients with poor medication adherence for 5-ASA drugs Cases using 5-ASA topical therapy (suppository, enema preparation) within 1 week of endoscopy Patient who used steroid formulation (suppository, enema, oral steroid formulation, steroid injectable formulation) or biologic formulation within 2 weeks of endoscopic enrollment. Patients with Crohn's disease or peptic ulcer Patients with history of colorectal surgery Patients with severe renal and liver impairment
研究者
相似试验
已完成
不适用
Comparison of concentration of 5-ASA and acetyl 5-ASA in mucosa in time-dependent mesalazine granule preparation and pH-dependent mesalazine tablet for patients with ulcerative colitislcerative colitisJPRN-UMIN000026175Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University60
已完成
不适用
Comparative study for mucosal concentration of 5-ASA by once-daily vs divided dosing of oral mesalazine in quiescent ulcerative colitisulcerative colitisJPRN-UMIN000010127Department of Gastroenterology and Hepatology, Kyoto University Hospital50
尚未招募
不适用
Persistence of oral 5-ASA treatment in ulcerative colitis.lcerative ColitisJPRN-UMIN000048318MOCHIDA PHARMACEUTICAL CO., LTD.4,400
已完成
不适用
Study on the efficacy of 5ASA oral formula and suppository against relapse of proctitisproctitisJPRN-UMIN000014838TT Medical Center Tokyo140
已完成
不适用
Exploring the role of faecal mesalazine (5-ASA) concentrations in therapeutic drug monitoring in ulcerative colitis: a pilot study.NL-OMON48827Maag, darm, leverziekten28